Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2001, p. 3456-3461, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3456-3461.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Measurement of Effects of Antibiotics in
Bioluminescent Staphylococcus aureus RN4220
Mervi
Tenhami,
Kaisa
Hakkila, and
Matti
Karp*
University of Turku, Department of
Biotechnology, Turku, Finland
Received 20 October 2000/Returned for modification 30 May
2001/Accepted 17 September 2001
 |
ABSTRACT |
The spread of antibiotic resistance among pathogenic bacteria is a
serious threat to humans and animals. Therefore, unnecessary use should
be minimized, and new antimicrobial agents with novel mechanisms of
action are needed. We have developed an efficient method for measuring
the action of antibiotics which is applied to a gram-positive strain,
Staphylococcus aureus RN4220. The method utilizes the
firefly luciferase reporter gene coupled to the metal-inducible cadA promoter in a plasmid, pTOO24. Correctly timed
induction by micromolar concentrations of antimonite rapidly triggers
the luciferase gene transcription and translation. This sensitizes the
detection system to the action of antibiotics, and especially for
transcriptional and translational inhibitors. We show the results for
11 model antibiotics with the present approach and compare them to an
analytical setup with a strain where luciferase expression is under the
regulation of a constitutive promoter giving only a report of metabolic
inhibition. The measurement of light emission from intact living cells
is shown to correlate extremely well (r = 0.99)
with the conventional overnight growth inhibition measurement. Four of
the antibiotics were within a 20% concentration range and four were
within a 60% concentration range of the drugs tested. This approach
shortens the assay time needed, and it can be performed in 1 to 4 h, depending on the sensitivity needed. Furthermore, the assay can be
automatized for high-throughput screening by the pharmaceutical industry.
 |
INTRODUCTION |
The gram-positive pathogenic
staphylococcus Staphylococcus aureus is considered a threat
to human health due to its capacity to efficiently infect hospital
patients with weakened immune status. The methicillin-resistant
S. aureus (MRSA) has been found in serious hospital
outbreaks that have proved difficult to treat. Together with
methicillin resistance, MRSA has also obtained other resistances through evolution, thereby making the situation even
worse (for a review, see reference 7). The recent
development of MRSA outbreaks and the emergence of resistant strains of
Mycobacterium tuberculosis among others have led to a new
interest in the pharmaceutical industry in searching for new
antimicrobial agents. High-throughput screening (HTS)
technologies applied to high-diversity combinatorial chemistry
molecular libraries make it possible to find lead molecules with new
modes of action as antimicrobial agents.
Luciferases are a heterologous group of intriguing proteins that
produce visible light, i.e., bioluminescence. There do not appear to exist any evolutionary relationships between different luciferases in a wide variety of species capable of bioluminescence. Molecular oxygen is the only common factor needed for emission of light
by the luciferases. Other substrates and cofactors show wide
chemical varieties (15, 17). The most well-known
bioluminescence phenomenon is from the North American firefly,
Photinus pyralis. The enzymatic reaction is as
follows: luciferase ATP + D-luciferin + O2 ======
AMP + oxyluciferin + PPi + CO2 + light (~560 nm)
The firefly luciferase gene is by far the reporter of
choice, not only due to its very sensitive detection limit of 0.05 amol/sample (10) but also because it has been used
in commercial detection reagents and vectors for long time. As a
consequence of all this, it has been expressed in a very wide variety
of cell types of procaryotic and eucaryotic origin (3).
Expression of the firefly luciferase gene inserted under the control of
a regulatory element to be studied allows the quantitation of factors
affecting this regulation specifically in real time. Furthermore,
various regulatory circuits and their control, such as signal
transduction via G-protein-coupled receptors, can be studied by
simple measurement of light emission from intact living cells (reviewed
in reference 8).
Recently, the bacterial luciferase operon modified for expression in
gram-positive organisms was used to study the infection process of
S. aureus in living mice (2). This system does
not necessitate the external addition of any substrates for
bioluminescence. On the other hand, the firefly luciferase gene has
been expressed in S. aureus by members of our group and
others (11, 12). These studies showed that detection of
light emission from intact living cells can be done after the addition
of D-luciferin. In our study we used the
firefly luciferase gene as a sensitive reporter of heavy metal
contamination by inserting the gene under a metal-responsive genetic
element, cadA, of the staphylococcal plasmid pI258
(12). Here we have applied this system for the measurement
of action against the S. aureus RN4220 reporter strain, and
we show that the system is sensitized to different antimicrobial
agents. The sensor can be triggered to produce luciferase protein by
inducing the encoding gene with various metal ions, such as
Cd2+, Pb2+,
Hg2+, Zn2+, and antimonite
ions (SbO2
). Cadmium ions are
the best inducers, but instead, in this study, we used less toxic
antimonite ions (1.0 µM) to induce the luciferase synthesis. Since
the machinery is rapidly turned on, the action of transcriptional and
translational inhibitors will especially have an effect on light
production. Bioluminescence measurements can be performed from the
beginning of the assay till the end in microtitration plates, and hence
the strain can be used to screen large chemical libraries. We show that
the results obtained closely correlate with those from conventional
overnight cultivation experiments.
 |
MATERIALS AND METHODS |
Materials.
All the antibiotics were from Sigma except for
chloramphenicol and erythromycin, which were from Serva Feinchemie
GmbH&Co, (Heidelberg, Germany), and ciprofloxacin-HCl, which was from
Bayer. The antibiotic stock solutions were stored frozen at
20°C at a concentration of 10 or 40 mg/ml. The cultivation media were from
Difco. D-luciferin was from BioOrbit Oy (Turku, Finland). Antimonite
(C4H4KO7Sb)
was of purum grade (
99%) from Fluka. The buffer chemicals were from
Sigma. All stocks and dilutions of chemicals were made into ultra-pure
commercial infusion grade water (Pharmacia, Uppsala, Sweden).
Bacterial strains.
The bacterial strains S. aureus RN4220/pCSS810 and S. aureus RN4220/pTOO24 used
in this study have been characterized previously (12). The
strain S. aureus RN4220/pCSS810 produces firefly luciferase constitutively. In strain S. aureus RN4220/pTOO24, the
firefly luciferase production is under the control of the
cadA promoter and cadC regulatory protein
of the staphylococcal plasmid pI258 (9, 18).
Cultivation of bacteria.
Both of the strains were cultivated
in Luria-Bertani (LB) medium containing kanamycin (30 µg/ml) at
30°C. The cells were grown to an optical density at 600 nm of 1.5 and
subjected to an ice bath after a 1-to-20 dilution with the medium until
further use.
Fifty-percent-inhibitory-concentration (IC50)
measurements by cultivation.
The diluted cells (1 ml) were added
to 14-ml Falcon tubes containing 0.5 ml of different antibiotic
dilutions in LB and 0.5 ml of broth (LB plus kanamycin [30 µg/ml]).
The cells were grown for 12 h at 30°C with shaking (250 rpm),
after which the optical density was measured at 600 nm with from 1 to
10 dilutions.
Antibiotic treatments and measurement of light emission.
A
schematic presentation of the pipetting order and typical light
emission pattern are shown in Fig. 1 to
visualize the approaches. A suitable dilution of the cells, either
RN4220/pTOO24 or RN4220/pCSS810 (50 µl), was dispensed into white
96-well microtitration plate wells and preincubated with different
antibiotics, labeled as samples S1, S2 and S3 (25 µl diluted into
H20) at 30°C. For Fig. 1A, the firefly
luciferase reporter synthesis was triggered by adding the inducer
antimonite (25 µl) to a 1 µM concentration, and incubation was
continued. For Fig. 1B, water instead of the inducer was pipetted to
the constitutive expression system. Light emission was obtained after
the addition of the luciferase substrate, D-luciferin,
which was added after 90 min at concentration of 0.5 mM (100 µl) in
an appropriate buffer (see below). The bioluminescence was measured
immediately after the dispensing of the substrate using a
Labsystems Luminoskan microtitration plate luminometer (Helsinki,
Finland) with an integral type of measurement for 5 s. In some
cases the measurement reading was repeated after 30 min.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Flow chart and a schematic representation of the
response curves for inducible- and constitutive-expression-based
methods. Diagrams A and B show how the light emission changes in
the two methods during the assay, as if the substrate for
D-luciferin were already present at the beginning. In
reality, the substrate is added at 90 min (dotted line changes to solid
one) as calculated from the end of the preincubation period. The curves
in diagram A (the inducible system) indicate that the amount of
luciferase protein, shown as RLU, at time point zero min is negligible,
and it start to accumulate only after the inducer is added as a
function of drug samples S1 to S3 affecting the system in comparison to
water control (C). On the other hand, in the constitutive expression
method B, a large amount of luciferase protein is already present in
the sensor cells, the activity of which is being affected more or less
by samples S1 to S3 and is compared to the control (C), unaffected
measurement.
|
|
Measurement of pH dependence.
For the study of the optimal
pH for the D-luciferin substrate penetration inside the
reporter cells, 50 mM Na-citrate, morpholineethanesulfonic acid (MES)
and morpholinepropanesulfonic acid (MOPS) buffers were used. The cells
were preincubated for 90 min at room temperature together with
different concentrations of the test antibiotic chloramphenicol, after
which they were challenged by adding the antimonite inducer to a 1 µM
concentration. After an induction period of 120 min, 100 µl of 1 mM
D-luciferin (final concentration, 0.5 mM in the measurement
cuvette) in different buffers was added by using a manual dispenser and
measured for the immediate bioluminescence emission. The measurements
were done in three parallel determinations, and they were repeated twice.
 |
RESULTS |
The experimental setup.
The metal-inducible reporter system
utilizing bioluminescent S. aureus RN4220/pTOO24 for the
measurement of the presence of certain heavy metals has been described
earlier (12). In this study the reporter system is applied
for a different purpose, and emphasis was put on optimizing the sensor
system for the measurement of the effects of various antimicrobial
agents. The synthesis of the reporter enzyme, firefly luciferase, was
turned on by using antimonite ions as inducing molecules. We studied
the optimal preincubation time from
120 min to zero by incubating a
suitable dilution of freshly cultivated sensor cells together with
different concentrations of a model antibiotic, chloramphenicol. It was found that 90 min is enough to obtain a full response, i.e., maximal test drug penetration through the staphylococcal cell membrane (data
not shown). It should be noted that in the fishing of leads from
combinatorial libraries, the preincubation period plays a major role.
If one wants to screen for well-penetrating compounds, then the
preincubation period should be decreased to a few minutes rather than
90 min, shown in Fig. 1. A schematic presentation as a flow
chart and response curves is shown in Fig. 1. Figure 1A shows the
inducible system, and panel B shows response curves for the
constitutive expression system. In the metal-inducible system, the
luciferase production starts as the inducer is added. If toxic
antibiotics are present, the level of synthesis will be lower than that
for the control nontreated sample. In the constitutive system the
reporter cells already contain a certain amount of the luciferase
enzyme at the beginning of the experiment, and addition of antibiotic
samples results mainly in metabolic inhibition, such as depletion of
the intracellular ATP pool.
The dependence of bioluminescence on pH.
Different buffers
were used to study the transport of the substrate for firefly
luciferase, D-luciferin, inside the S. aureus/pTOO24 cells. The pH profile from 4.6 to 7.0 using Na
citrate, MES, and MOPS buffers is shown in Fig.
2. We studied two different parameters simultaneously, namely, the functionality of the cells as measured by
the induction capacity (induction factor) and responsiveness to the
action of different concentrations of chloramphenicol. In the optimum
pH of 6.6 (the inducible system), the light emission signal (Fig. 2A)
and induction factor were the highest, and the inhibitory effect of
chloramphenicol could be clearly quantitated (data not shown). The
control experiment with constitutive light production (Fig. 2B) gave
similar results. From this experiment with light emission, measurements
were done with MOPS buffer at pH 6.6.

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 2.
The pH dependency of light production of S.
aureus RN4220/pTOO24 and RN4220/pCSS810 cells. The assay was
performed in citrate-phosphate buffer (pH range, 4.6 to 5.6 [ ]),
MES (pH range, 5.6 to 6.6 [ ]) and MOPS (pH range, 6.6 to 7.0 [ ]) as described in Materials and Methods. Panel A shows the pH
dependency of D-luciferin penetration into the indicator
RN4220/pTOO24 cells, and Panel B shows results for strain
RN4220/pCSS810.
|
|
The bioluminescence response of S. aureus towards
model antibiotics.
Selected model antibiotics belonging to
different molecular families and also having different mechanisms of
action were tested for effects against RN4220/pTOO24 (inducible system)
and against RN4220/pCSS810 (constitutive production of luciferase). The
cells were kept together with different dilutions of antibiotics at room temperature for a 90-min preincubation period at pH 7.0. The
results of this experiment are given in Table
1, showing a comparison in selected low
and high concentrations of antibiotics. Both the inducible and the
constitutive system contain a chloramphenicol acetyltransferase gene
(cat) in the reporter plasmid downstream of the luciferase
gene (12). In the constitutive system, the artificial
operon is under a strong T5 promoter (5), whereas in the inducible system it is under the control of a relatively weak
cadA promoter. As is evident from the table when comparing the chloramphenicol inhibition data, the cat gene does not
work in the inducible system, and one could also speculate that the expression of cat in the constitutive system is not optimal
for S. aureus in this experimental setup. Furthermore, the
inducible system is in all but one case (that of sulfadiazine) more
sensitive than the constitutive system. The power of the induction
system is especially well seen with rifampin and tetracycline, where extremely low concentrations (a few nanograms per milliliter) make a
clear-cut difference when comparing inducible and constitutive systems
with low and high concentrations. Please note that the concentrations
shown in Table 1 are different in the low and high range in the
inducible and constitutive system for some of the antibiotics to obtain
reasonable numbers (those that differ considerably from 0%). The
coefficients of variation in the inducible system were 2 to 6% as
measured with three replicas from original relative light units (RLUs).
The coefficients of variation in the constitutive system were 2 to 7%
as measured with three replicas from original RLUs.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Comparison between the bioluminescent inducible and
constitutive expression systems for the detection of antimicrobial
action powera
|
|
Correlation between rapid bioluminescence measurement and
conventional growth inhibition.
Three typical dose-response curves
for the inducible system and conventional cultivation are shown in Fig.
3 to visualize how similar the two
measurement methods are. We sometimes encounter situations when very
small, nanogram amounts of certain antimicrobial agents cause minor
activation of bioluminescence. This is seen here especially in the case
of rifampin, which causes a 40% activation with 1-ng/ml concentration
in the assay. Similar activation was found with ampicillin (100 ng/ml),
cefotaxime (10 ng/ml), norfloxacin (100 ng/ml), spiramycin (100 ng/ml),
and tetracycline (2 ng/ml). These slight activation phenomena with low
doses may be results of small changes in consumption of cellular ATP
pools that are increases in partial inhibition of metabolic routes by
the antibiotics. Activation was also seen in the growth inhibition
assay in the case of rifampin, which increased the viability by 15% at
a 1-ng/ml concentration.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Typical growth inhibition and luminescence inhibition
curves for three antibiotics. S. aureus RN4220/pTOO24
cells were treated with various concentrations of rifampin (A and D),
tetracycline (B and E), and ciprofloxacin (C and F). The conventional
overnight cultivation is shown in panels A, B, and C, and luminescence
inhibition is shown in panels D, E, and F. The assays were performed as
described in Materials and Methods.
|
|
Table
2 shows the
IC
50 values for all antibiotics for the strain
RN4220/pTOO24 as measured by the inducible bioluminescence
system and a
conventional growth inhibition assay. Sulfadiazine
and trimethoprim
were omitted from this table since IC
50 values
could not be counted. The correlation factor between the two methods
was an
r value of 0.99. Strain RN4220/pCSS810 did not show
any
differences in conventional growth inhibition experiments (data
not
shown).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
IC50 values for nine antibiotics for the
strain RN4220/pTOO24 as measured by an inducible bioluminescence
system and a conventional growth inhibition assay
|
|
 |
DISCUSSION |
The search for new antimicrobial drugs is currently very intensive
and should be done more effectively now, since combinatorial chemistry
approaches have been available for a decade (reviewed in reference
1). The generation of tens of thousands of lead compounds
calls for efficient screening technologies (HTS or
ultra-high-throughput screening). Long-term cultivation is an end-point
method that answers the question of whether the indicator bacteria are
living or not. It does not tell anything of the mode of action of the antibiotic tested. Certain groups of lead candidates with antimicrobial action may be more easily identified in a false screening
procedure, and this predomination results in biased hit-scoring from a
chemical library. It may happen that only agents that affect membranes can be fished out of the chemicals pool. Also, if a library is initially screened by pooling the compounds to decrease the number of
measurements, this biased situation may result in the loss of valuable
gold nuggets in the panning process. Therefore, new tools should be
generated which allow a more targeted search, emphasizing the
possibility of finding compounds with predetermined characteristics.
We have approached this question by making several improvements to
existing functional microbial methods. First, we used the luciferase
gene, the action of which can be monitored in real time from living
cells. This resulted in a considerable savings in assay time, since
results are obtained in tens of minutes rather than in several hours or
even days. This also opens the possibility of screening a vast amount
of compounds, since 96- or 384-well plates can be used. Second, we have
inserted the luciferase gene under an inducible promoter, which
resulted in specific amplification of the effects of those agents that
affect transcription and translation in particular. This resulted in a
further time savings, since induction of luciferase synthesis can be
triggered at a predetermined time point. Third, we have generated a
system that works in a nonpathogenic type strain of S. aureus, RN4220, (4), which works as a model system
for its pathogenic relative, MRSA. Finally, we used the firefly
luciferase as a marker gene and protein. Since one of the substrates is
ATP, an essential energy source of each living cell, any disturbances
in the intracellular level are directly reflected in light emission
levels measured from the reporter cells. Therefore, minor events
happening before the bacteria are killed are detected as a decreased
emission of light.
One of the commonly proposed pitfalls for insect luciferase reporter
genes is their lack of intrinsic luminescence capability and the need
to disrupt the cells prior to D-luciferin addition and
measurement. However, for a long time it has been known that measurement from intact living Escherichia coli cells
carrying the firefly luciferase gene works perfectly well when
D-luciferin is being incorporated inside the
cells in a protonated form at pH 5.0 (16). In a recent
study members of our group showed that it is actually wiser to measure
luciferase reporter activity from intact living cells using the pH
method in order to obtain more reproducible results than with disrupted
E. coli cells and in vitro activity measurement
(13). Various bacterial strains behave somewhat
differently with regard to D-luciferin
penetration inside cells. We have previously shown that
Streptococcus mutans has an optimum pH of 6.0, indicating
the effect of the different molecular structure of a gram-positive
cellular membrane (6). Likewise, here we have shown that
another gram-positive organism, S. aureus, has an even more
neutral optimum pH for D-luciferin incorporation, with the optimum at pH 6.6 (Fig. 2). One could speculate that such a pH
might allow one to incubate S. aureus cells in the presence of the substrate for a luciferase reaction from the beginning of the
assay, making it possible to continually monitor the effects of
different antibiotics. It remains to be seen whether this kind of
approach could be valid and whether it could be applied to homogenous
HTS applications in the future.
Members of our group have previously shown a similar amplification
approach, described in this study, to be valid with E. coli, where certain model analytes were tested with a system
consisting of a strong and inducible
pL promoter controlling expression of
various luciferase genes (5). In that study the effects of
translational inhibitors, for instance, were seen in as much as
10,000-fold-lower concentrations than with the constitutive approach.
It was also noticed that metabolic inhibitors affected both systems
rather similarly during the short incubation period used. The fact that
the effects of certain antibiotics were much greater than in this study
is because the phage
pL promoter is
one of the strongest ones reported. This results in extremely high amplification of the effects of antimicrobial agents. In this
study we have shown that the previous experience with E. coli is also applicable to a gram-positive human pathogen,
S. aureus. We have also previously freeze-dried several
strains of light-emitting bacteria (with either a constitutive or an
inducible system) and shown that such cells, once reconstituted, are
fully functional and behave as though they are freshly cultivated
(5, 12-14). This fact creates an opportunity to use these
indicator cells as ordinary reagents that can be taken from the shelf
for direct use without any need for cultivation or complicated
incubations whose operations do not fit with the tight time schedules
of HRA.
Recently an engineered bacterial luciferase operon that was optimized
to work in gram-positive organisms was described (2). The
construction was expressed in S. aureus and used for
monitoring the infection process in living mice utilizing a sensitive
charge-coupled-device camera and digital image processing. The
bacterial infection was experimentally shown to be cured by amoxicillin
treatment as judged by the disappearance of in vivo light emission and
correlation with CFU counting. This study shows how powerful
bioluminescence technologies are in studies concerning antibiotic
action against microbial cells. In this study we have generated a
system for amplifying the effects of antibiotics and characterized it
with model compounds of different modes of action. The approach was shown to correlate extremely well with the conventional growth inhibition method, and the amplification resulted in a clear
improvement in sensitive detection of antibiotic action compared to the
constitutive expression system. The system should be readily scaled up
for HTS purposes.
 |
ACKNOWLEDGMENTS |
We thank Marko Virta and Jussi Kurittu for fruitful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Turku, Department of Biotechnology, Tykistökatu 6, 6th floor,
FIN-20520 Turku, Finland. Phone: 358-2-3338085. Fax: 358-2-3338050. E-mail: matti.karp{at}utu.fi.
 |
REFERENCES |
| 1.
|
Birnbaum, S., and K. Mosbach.
1992.
Peptide screening.
Curr. Opin. Biotechnol.
3:49-54[CrossRef][Medline].
|
| 2.
|
Francis, K. P.,
D. Joh,
C. Bellinger-Kawahara,
M. J. Hawkinson,
T. F. Purchio, and P. R. Contag.
2000.
Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct.
Infect. Immun.
68:3594-3600[Abstract/Free Full Text].
|
| 3.
|
Gelmini, S.,
P. Pinzani, and M. Pazzagli.
2000.
Luciferase gene as reporter: comparison with the CAT gene and use in transfection and microinjection of mammalian cells.
Methods Enzymol.
305:557-576[Medline].
|
| 4.
|
Kreiswirth, B. N.,
S. Lofdahl,
M. J. Betley,
M. O'Reilly,
P. M. Schlievert,
M. S. Bergdoll, and R. P. Novick.
1983.
The toxic shock syndrome exotoxin structural gene is not detectable transmitted by a prophage.
Nature
305:709-712[CrossRef][Medline].
|
| 5.
|
Lampinen, J.,
M. Virta, and M. Karp.
1995.
Use of controlled luciferase expression to monitor chemicals affecting protein synthesis.
Appl. Environ. Microbiol.
61:2981-2989[Abstract].
|
| 6.
|
Loimaranta, V.,
J. Tenovuo,
L. Koivisto, and M. Karp.
1998.
Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of antimicrobial compounds.
Antimicrob. Agents Chemother.
42:1906-1910[Abstract/Free Full Text].
|
| 7.
|
Mazel, D., and J. Davies.
1999.
Antibiotic resistance in microbes.
Cell. Mol. Life Sci.
56:742-754[CrossRef][Medline].
|
| 8.
|
Milligan, G., and S. Rees.
1999.
Chimaeric G proteins: their potential use in drug discovery.
Trends Pharmacol. Sci.
20:118-124[CrossRef][Medline].
|
| 9.
|
Nucifora, G.,
L. Chu,
T. K. Misra, and S. Silver.
1989.
Cadmium resistance from Staphylococcus aureus plasmid pI258 cadA gene results from cadmium-efflux ATPase.
Proc. Natl. Acad. Sci. USA
86:3544-3548[Abstract/Free Full Text].
|
| 10.
|
Pazzagli, M.,
J. H. Devine,
D. O. Peterson, and T. O. Baldwin.
1992.
Use of bacterial and firefly luciferases as reporter genes in DEAE-dextran-mediated transfection of mammalian cells.
Anal. Biochem.
204:315-323[CrossRef][Medline].
|
| 11.
|
Steidler, L.,
W. Yu,
W. Fiers, and E. Remaut.
1996.
The expression of Photinus pyralis gene in Staphylococcus aureus Cowan I allows the development of a live amplifiable tool for immunoprotection.
Appl. Environ. Microbiol.
62:2356-2359[Abstract].
|
| 12.
|
Tauriainen, S.,
M. Karp,
W. Chang, and M. Virta.
1998.
Luminescent bacterial sensor for cadmium and lead.
Biosens. Bioelectronics
13:931-938[CrossRef][Medline].
|
| 13.
|
Tauriainen, S.,
M. Virta,
W. Chang, and M. Karp.
1999.
Measurement of firefly luciferase reporter gene activity from cells and lysates using Escherichia coli arsenite and mercury sensors.
Anal. Biochem.
272:191-198[CrossRef][Medline].
|
| 14.
|
Tauriainen, S.,
M. Virta, and M. Karp.
2000.
Detecting bioavailable toxic metals and metalloids from natural water samples using luminescent sensor bacteria.
Water Res.
34:2661-2666[CrossRef].
|
| 15.
|
Wilson, T., and J. W. Hastings.
1998.
Bioluminescence.
Annu. Rev. Cell Dev. Biol.
14:197-230[CrossRef][Medline].
|
| 16.
|
Wood, K. V., and M. DeLuca.
1987.
Photographic detection of luminescence in Escherichia coli containing the gene for firefly luciferase.
Anal. Biochem.
161:501-507[CrossRef][Medline].
|
| 17.
|
Wood, K. V.
1995.
The chemical mechanism and evolutionary development of beetle bioluminescence.
Photochem. Photobiol.
62:662-673.
|
| 18.
|
Yoon, K. P., and S. Silver.
1991.
A second gene in the Staphylococcus aureus cadA cadmium resistance determinant of plasmid pI258.
J. Bacteriol.
173:7636-7642[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, December 2001, p. 3456-3461, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3456-3461.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Guo, B., Zhao, X., Shi, Y., Zhu, D., Zhang, Y.
(2007). Pathogenic Implication of a Fibrinogen-Binding Protein of Staphylococcus epidermidis in a Rat Model of Intravascular-Catheter-Associated Infection. Infect. Immun.
75: 2991-2995
[Abstract]
[Full Text]
-
Mortin, L. I., Li, T., Van Praagh, A. D. G., Zhang, S., Zhang, X.-X., Alder, J. D.
(2007). Rapid Bactericidal Activity of Daptomycin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Peritonitis in Mice as Measured with Bioluminescent Bacteria. Antimicrob. Agents Chemother.
51: 1787-1794
[Abstract]
[Full Text]
-
Qazi, S., Middleton, B., Muharram, S. H., Cockayne, A., Hill, P., O'Shea, P., Chhabra, S. R., Camara, M., Williams, P.
(2006). N-Acylhomoserine Lactones Antagonize Virulence Gene Expression and Quorum Sensing in Staphylococcus aureus. Infect. Immun.
74: 910-919
[Abstract]
[Full Text]
-
Jawhara, S., Mordon, S.
(2004). In Vivo Imaging of Bioluminescent Escherichia coli in a Cutaneous Wound Infection Model for Evaluation of an Antibiotic Therapy. Antimicrob. Agents Chemother.
48: 3436-3441
[Abstract]
[Full Text]
-
Qazi, S. N. A., Harrison, S. E., Self, T., Williams, P., Hill, P. J.
(2004). Real-Time Monitoring of Intracellular Staphylococcus aureus Replication. J. Bacteriol.
186: 1065-1077
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Kimura, R., Purchio, T., Contag, P. R.
(2003). Rapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm Infection. Antimicrob. Agents Chemother.
47: 3130-3137
[Abstract]
[Full Text]
-
Galluzzi, L., Karp, M.
(2003). Amplified Detection of Transcriptional and Translational Inhibitors in Bioluminescent Escherichia Coli K-12. J Biomol Screen
8: 340-346
[Abstract]
-
Kadurugamuwa, J. L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., Rubin, M., Bellinger-Kawahara, C., Parr, T. R. Jr., Contag, P. R.
(2003). Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model. Infect. Immun.
71: 882-890
[Abstract]
[Full Text]